semaglutide fda approval date approves first-ever oral GLP-1RA for obesity and chronic weight management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults A stronger 7.2 mg dose

Hooymans JM, Ballegooie EV, Schweitzer NM, Doorebos H, Reitsma WD, Slutter WJ

However, the clinical benefit of tapering versus abrupt discontinuation has not been formally studied for tirzepatide

Retatrutide, by contrast, distributes its effect across three pathways

Your GP may consider alternatives to weight-promoting medications where clinically appropriate

Yes, though it does require a bit more coordination than the abdomen or thigh

This study was funded by the National Natural Science Foundation of China (82474560, 82104914), the Natural Science Foundation of Shandong Province of China (ZR2023MH112), 2024 Shenzhen Luohu District Soft Science Research Program (LX202402023)